30 augustus 2021

World-first trial tests cannabis-based drug on aggressive brain tumours

A major UK trial of cannabis-based drug Sativex in treating the most aggressive form of brain tumour is to launch at 15 NHS hospitals, following promising results from a phase I study in 27 patients.

The new phase II trial, led by the University of Leeds, will assess whether adding Sativex – an oral spray containing cannabinoids THC and CBD – to chemotherapy, could extend life for thousands diagnosed with a recurrent glioblastoma. Currently, it has an average survival of less than 10 months.

The drug, already used in treating multiple sclerosis, was found to be tolerable in combination with chemotherapy, with the potential to extend survival, in a phase I trial in glioblastomas earlier this year.

Read the whole article

Share this on Facebook
Thanks to our friends @
CNNBS

RELATED NEWS

Medicines and CBD purposes
25 mei 2020

Everything about CBD

Cannabidiol is one of more than 400 compounds found in the cannabis plant, more than 60 of which are unique to cannabis itself. Unlike tetrahydrocannabinol, CBD is not psychoactive. But like THC, cannabidiol has a long list of medicinal benefits.

more
5 mei 2022

Jouw endocannabinoïden-systeem uitgelegd

In deze educatieve video legt medicinaal cannabis-expert drs. Dustin Sulak het endocannabinoïden-systeem uit. Hij vertelt over de rol die het speelt bij het handhaven van harmonie en balans in jouw...

more